Director/PDMR Shareholding | 17-Apr-2024 | 10:42 | RNS |
Hikma appoints new President of Generics business | 15-Apr-2024 | 16:43 | RNS |
Director/PDMR Shareholding | 11-Apr-2024 | 10:58 | RNS |
Block listing Interim Review | 02-Apr-2024 | 09:50 | RNS |
Annual Financial Report and Notice of AGM | 22-Mar-2024 | 09:21 | RNS |
Director/PDMR Shareholding | 13-Mar-2024 | 09:42 | RNS |
Director/PDMR Shareholding | 07-Mar-2024 | 13:52 | RNS |
Total Voting Rights | 01-Mar-2024 | 10:17 | RNS |
Final Results | 22-Feb-2024 | 07:00 | RNS |
Notice of Results | 05-Feb-2024 | 08:46 | RNS |
Agreement in Principle for US Opioid Settlement | 01-Feb-2024 | 18:22 | RNS |
Total Voting Rights | 01-Feb-2024 | 12:08 | RNS |
Total Voting Rights | 02-Jan-2024 | 15:24 | RNS |
Company Secretary Change | 29-Dec-2023 | 07:00 | RNS |
Total Voting Rights | 01-Dec-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 1,799.00p |
Change Today | 10.00p |
% Change | 0.56 % |
52 Week High | 2,205.00 |
52 Week Low | 1,722.00 |
Volume | 309,831 |
Shares Issued | 221.89m |
Market Cap | £3,991.72m |
RiskGrade | 125 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 1 |
Strong Sell | 0 |
Total | 11 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 21-Mar-24 | 10-Aug-23 |
Paid | 03-May-24 | 15-Sep-23 |
Amount | 47.00¢ | 25.00¢ |
Time | Volume / Share Price |
16:35 | 185,849 @ 1,799.00p |
16:35 | 362 @ 1,799.00p |
16:35 | 397 @ 1,799.00p |
16:35 | 931 @ 1,799.00p |
16:35 | 2,390 @ 1,799.00p |
You are here: research